Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses

HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cellular-mediated cytotoxicity (ADCC). HIV-1 has evolved sophisticated mechanisms to avoid the exposure of Env ADCC epitopes by downregulating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of virology 2017-04, Vol.91 (7)
Hauptverfasser: Prévost, Jérémie, Zoubchenok, Daria, Richard, Jonathan, Veillette, Maxime, Pacheco, Beatriz, Coutu, Mathieu, Brassard, Nathalie, Parsons, Matthew S, Ruxrungtham, Kiat, Bunupuradah, Torsak, Tovanabutra, Sodsai, Hwang, Kwan-Ki, Moody, M Anthony, Haynes, Barton F, Bonsignori, Mattia, Sodroski, Joseph, Kaufmann, Daniel E, Shaw, George M, Chenine, Agnès L, Finzi, Andrés
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 7
container_start_page
container_title Journal of virology
container_volume 91
creator Prévost, Jérémie
Zoubchenok, Daria
Richard, Jonathan
Veillette, Maxime
Pacheco, Beatriz
Coutu, Mathieu
Brassard, Nathalie
Parsons, Matthew S
Ruxrungtham, Kiat
Bunupuradah, Torsak
Tovanabutra, Sodsai
Hwang, Kwan-Ki
Moody, M Anthony
Haynes, Barton F
Bonsignori, Mattia
Sodroski, Joseph
Kaufmann, Daniel E
Shaw, George M
Chenine, Agnès L
Finzi, Andrés
description HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cellular-mediated cytotoxicity (ADCC). HIV-1 has evolved sophisticated mechanisms to avoid the exposure of Env ADCC epitopes by downregulating CD4 and by limiting the overall amount of Env on the cell surface. In HIV-1, substitution of large residues such as histidine or tryptophan for serine 375 (S375H/W) in the gp120 Phe 43 cavity, where Phe 43 of CD4 contacts gp120, results in the spontaneous sampling of an Env conformation closer to the CD4-bound state. While residue S375 is well conserved in the majority of group M HIV-1 isolates, CRF01_AE strains have a naturally occurring histidine at this position (H375). Interestingly, CRF01_AE is the predominant circulating strain in Thailand, where the RV144 trial took place. In this trial, which resulted in a modest degree of protection, ADCC responses were identified as being part of the correlate of protection. Here we investigate the influence of the Phe 43 cavity on ADCC responses. Filling this cavity with a histidine or tryptophan residue in Env with a natural serine residue at this position (S375H/W) increased the susceptibility of HIV-1-infected cells to ADCC. Conversely, the replacement of His 375 by a serine residue (H375S) within HIV-1 CRF01_AE decreased the efficiency of the ADCC response. Our results raise the intriguing possibility that the presence of His 375 in the circulating strain where the RV144 trial was held contributed to the observed vaccine efficacy. HIV-1-infected cells presenting Env in the CD4-bound conformation on their surface are preferentially targeted by ADCC mediated by HIV-positive (HIV ) sera. Here we show that the gp120 Phe 43 cavity modulates the propensity of Env to sample this conformation and therefore affects the susceptibility of infected cells to ADCC. CRF01_AE HIV-1 strains have an unusual Phe 43 cavity-filling His 375 residue, which increases the propensity of Env to sample the CD4-bound conformation, thereby increasing susceptibility to ADCC.
doi_str_mv 10.1128/JVI.02452-16
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5355605</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1891873821</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-221b901ba9c72826ec13e9c580538c9b6d8160c2672b48aa63c86e7439bc58443</originalsourceid><addsrcrecordid>eNqNkc1v1DAQxS0EosvCjTPykQMpHn_FuSBVodBFRSA-Km6W48y2Rlk7xN4Ve-B_J9uWCm6cRpr5zZt5eoQ8BXYMwM3LdxerY8al4hXoe2QBrDGVUiDvkwVjnFdKmG9H5FHO3xkDKbV8SI64AcY0mAX5tYrrYYvRI01rWq6QnsYdDmlEejkCZ_Tj3JKCtm4Xyp6mSM9WFxXQzxhzKOG6WRI9iSV0qd9Xr3HE2GMstMVhqN5jH1zBnrb7kkr6Gfxh4RPmMcWM-TF5sHZDxie3dUm-vjn90p5V5x_ertqT88pLEKXiHLqGQecaX3PDNXoQ2Hhl2GzON53uDWjmua55J41zWnijsZai6WZISrEkr250x223wd7P_01usOMUNm7a2-SC_XcSw5W9TDurhFJ6vrIkz28FpvRji7nYTch-dugipm22YBowtTAc_gPVoGpVw0H1xQ3qp5TzhOu7j4DZQ7h2Dtdeh2tBz_izv13cwX_SFL8B_QafDA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1861575715</pqid></control><display><type>article</type><title>Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses</title><source>Electronic Journals Library</source><source>PubMed Central (Open Access)</source><source>MEDLINE</source><creator>Prévost, Jérémie ; Zoubchenok, Daria ; Richard, Jonathan ; Veillette, Maxime ; Pacheco, Beatriz ; Coutu, Mathieu ; Brassard, Nathalie ; Parsons, Matthew S ; Ruxrungtham, Kiat ; Bunupuradah, Torsak ; Tovanabutra, Sodsai ; Hwang, Kwan-Ki ; Moody, M Anthony ; Haynes, Barton F ; Bonsignori, Mattia ; Sodroski, Joseph ; Kaufmann, Daniel E ; Shaw, George M ; Chenine, Agnès L ; Finzi, Andrés</creator><creatorcontrib>Prévost, Jérémie ; Zoubchenok, Daria ; Richard, Jonathan ; Veillette, Maxime ; Pacheco, Beatriz ; Coutu, Mathieu ; Brassard, Nathalie ; Parsons, Matthew S ; Ruxrungtham, Kiat ; Bunupuradah, Torsak ; Tovanabutra, Sodsai ; Hwang, Kwan-Ki ; Moody, M Anthony ; Haynes, Barton F ; Bonsignori, Mattia ; Sodroski, Joseph ; Kaufmann, Daniel E ; Shaw, George M ; Chenine, Agnès L ; Finzi, Andrés</creatorcontrib><description>HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cellular-mediated cytotoxicity (ADCC). HIV-1 has evolved sophisticated mechanisms to avoid the exposure of Env ADCC epitopes by downregulating CD4 and by limiting the overall amount of Env on the cell surface. In HIV-1, substitution of large residues such as histidine or tryptophan for serine 375 (S375H/W) in the gp120 Phe 43 cavity, where Phe 43 of CD4 contacts gp120, results in the spontaneous sampling of an Env conformation closer to the CD4-bound state. While residue S375 is well conserved in the majority of group M HIV-1 isolates, CRF01_AE strains have a naturally occurring histidine at this position (H375). Interestingly, CRF01_AE is the predominant circulating strain in Thailand, where the RV144 trial took place. In this trial, which resulted in a modest degree of protection, ADCC responses were identified as being part of the correlate of protection. Here we investigate the influence of the Phe 43 cavity on ADCC responses. Filling this cavity with a histidine or tryptophan residue in Env with a natural serine residue at this position (S375H/W) increased the susceptibility of HIV-1-infected cells to ADCC. Conversely, the replacement of His 375 by a serine residue (H375S) within HIV-1 CRF01_AE decreased the efficiency of the ADCC response. Our results raise the intriguing possibility that the presence of His 375 in the circulating strain where the RV144 trial was held contributed to the observed vaccine efficacy. HIV-1-infected cells presenting Env in the CD4-bound conformation on their surface are preferentially targeted by ADCC mediated by HIV-positive (HIV ) sera. Here we show that the gp120 Phe 43 cavity modulates the propensity of Env to sample this conformation and therefore affects the susceptibility of infected cells to ADCC. CRF01_AE HIV-1 strains have an unusual Phe 43 cavity-filling His 375 residue, which increases the propensity of Env to sample the CD4-bound conformation, thereby increasing susceptibility to ADCC.</description><identifier>ISSN: 0022-538X</identifier><identifier>EISSN: 1098-5514</identifier><identifier>DOI: 10.1128/JVI.02452-16</identifier><identifier>PMID: 28100618</identifier><language>eng</language><publisher>United States: American Society for Microbiology</publisher><subject>AIDS Vaccines - immunology ; Amino Acid Motifs ; Amino Acid Sequence ; Antibody-Dependent Cell Cytotoxicity ; Binding Sites ; Consensus Sequence ; HEK293 Cells ; HIV Antibodies - physiology ; HIV Envelope Protein gp120 - immunology ; HIV Infections - immunology ; HIV Infections - prevention &amp; control ; HIV Infections - virology ; HIV-1 - immunology ; Humans ; Lentivirus ; Pathogenesis and Immunity ; Protein Binding ; Retroviridae</subject><ispartof>Journal of virology, 2017-04, Vol.91 (7)</ispartof><rights>Copyright © 2017 American Society for Microbiology.</rights><rights>Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-221b901ba9c72826ec13e9c580538c9b6d8160c2672b48aa63c86e7439bc58443</citedby><cites>FETCH-LOGICAL-c413t-221b901ba9c72826ec13e9c580538c9b6d8160c2672b48aa63c86e7439bc58443</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355605/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355605/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28100618$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Prévost, Jérémie</creatorcontrib><creatorcontrib>Zoubchenok, Daria</creatorcontrib><creatorcontrib>Richard, Jonathan</creatorcontrib><creatorcontrib>Veillette, Maxime</creatorcontrib><creatorcontrib>Pacheco, Beatriz</creatorcontrib><creatorcontrib>Coutu, Mathieu</creatorcontrib><creatorcontrib>Brassard, Nathalie</creatorcontrib><creatorcontrib>Parsons, Matthew S</creatorcontrib><creatorcontrib>Ruxrungtham, Kiat</creatorcontrib><creatorcontrib>Bunupuradah, Torsak</creatorcontrib><creatorcontrib>Tovanabutra, Sodsai</creatorcontrib><creatorcontrib>Hwang, Kwan-Ki</creatorcontrib><creatorcontrib>Moody, M Anthony</creatorcontrib><creatorcontrib>Haynes, Barton F</creatorcontrib><creatorcontrib>Bonsignori, Mattia</creatorcontrib><creatorcontrib>Sodroski, Joseph</creatorcontrib><creatorcontrib>Kaufmann, Daniel E</creatorcontrib><creatorcontrib>Shaw, George M</creatorcontrib><creatorcontrib>Chenine, Agnès L</creatorcontrib><creatorcontrib>Finzi, Andrés</creatorcontrib><title>Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses</title><title>Journal of virology</title><addtitle>J Virol</addtitle><description>HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cellular-mediated cytotoxicity (ADCC). HIV-1 has evolved sophisticated mechanisms to avoid the exposure of Env ADCC epitopes by downregulating CD4 and by limiting the overall amount of Env on the cell surface. In HIV-1, substitution of large residues such as histidine or tryptophan for serine 375 (S375H/W) in the gp120 Phe 43 cavity, where Phe 43 of CD4 contacts gp120, results in the spontaneous sampling of an Env conformation closer to the CD4-bound state. While residue S375 is well conserved in the majority of group M HIV-1 isolates, CRF01_AE strains have a naturally occurring histidine at this position (H375). Interestingly, CRF01_AE is the predominant circulating strain in Thailand, where the RV144 trial took place. In this trial, which resulted in a modest degree of protection, ADCC responses were identified as being part of the correlate of protection. Here we investigate the influence of the Phe 43 cavity on ADCC responses. Filling this cavity with a histidine or tryptophan residue in Env with a natural serine residue at this position (S375H/W) increased the susceptibility of HIV-1-infected cells to ADCC. Conversely, the replacement of His 375 by a serine residue (H375S) within HIV-1 CRF01_AE decreased the efficiency of the ADCC response. Our results raise the intriguing possibility that the presence of His 375 in the circulating strain where the RV144 trial was held contributed to the observed vaccine efficacy. HIV-1-infected cells presenting Env in the CD4-bound conformation on their surface are preferentially targeted by ADCC mediated by HIV-positive (HIV ) sera. Here we show that the gp120 Phe 43 cavity modulates the propensity of Env to sample this conformation and therefore affects the susceptibility of infected cells to ADCC. CRF01_AE HIV-1 strains have an unusual Phe 43 cavity-filling His 375 residue, which increases the propensity of Env to sample the CD4-bound conformation, thereby increasing susceptibility to ADCC.</description><subject>AIDS Vaccines - immunology</subject><subject>Amino Acid Motifs</subject><subject>Amino Acid Sequence</subject><subject>Antibody-Dependent Cell Cytotoxicity</subject><subject>Binding Sites</subject><subject>Consensus Sequence</subject><subject>HEK293 Cells</subject><subject>HIV Antibodies - physiology</subject><subject>HIV Envelope Protein gp120 - immunology</subject><subject>HIV Infections - immunology</subject><subject>HIV Infections - prevention &amp; control</subject><subject>HIV Infections - virology</subject><subject>HIV-1 - immunology</subject><subject>Humans</subject><subject>Lentivirus</subject><subject>Pathogenesis and Immunity</subject><subject>Protein Binding</subject><subject>Retroviridae</subject><issn>0022-538X</issn><issn>1098-5514</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1v1DAQxS0EosvCjTPykQMpHn_FuSBVodBFRSA-Km6W48y2Rlk7xN4Ve-B_J9uWCm6cRpr5zZt5eoQ8BXYMwM3LdxerY8al4hXoe2QBrDGVUiDvkwVjnFdKmG9H5FHO3xkDKbV8SI64AcY0mAX5tYrrYYvRI01rWq6QnsYdDmlEejkCZ_Tj3JKCtm4Xyp6mSM9WFxXQzxhzKOG6WRI9iSV0qd9Xr3HE2GMstMVhqN5jH1zBnrb7kkr6Gfxh4RPmMcWM-TF5sHZDxie3dUm-vjn90p5V5x_ertqT88pLEKXiHLqGQecaX3PDNXoQ2Hhl2GzON53uDWjmua55J41zWnijsZai6WZISrEkr250x223wd7P_01usOMUNm7a2-SC_XcSw5W9TDurhFJ6vrIkz28FpvRji7nYTch-dugipm22YBowtTAc_gPVoGpVw0H1xQ3qp5TzhOu7j4DZQ7h2Dtdeh2tBz_izv13cwX_SFL8B_QafDA</recordid><startdate>20170401</startdate><enddate>20170401</enddate><creator>Prévost, Jérémie</creator><creator>Zoubchenok, Daria</creator><creator>Richard, Jonathan</creator><creator>Veillette, Maxime</creator><creator>Pacheco, Beatriz</creator><creator>Coutu, Mathieu</creator><creator>Brassard, Nathalie</creator><creator>Parsons, Matthew S</creator><creator>Ruxrungtham, Kiat</creator><creator>Bunupuradah, Torsak</creator><creator>Tovanabutra, Sodsai</creator><creator>Hwang, Kwan-Ki</creator><creator>Moody, M Anthony</creator><creator>Haynes, Barton F</creator><creator>Bonsignori, Mattia</creator><creator>Sodroski, Joseph</creator><creator>Kaufmann, Daniel E</creator><creator>Shaw, George M</creator><creator>Chenine, Agnès L</creator><creator>Finzi, Andrés</creator><general>American Society for Microbiology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U9</scope><scope>H94</scope><scope>5PM</scope></search><sort><creationdate>20170401</creationdate><title>Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses</title><author>Prévost, Jérémie ; Zoubchenok, Daria ; Richard, Jonathan ; Veillette, Maxime ; Pacheco, Beatriz ; Coutu, Mathieu ; Brassard, Nathalie ; Parsons, Matthew S ; Ruxrungtham, Kiat ; Bunupuradah, Torsak ; Tovanabutra, Sodsai ; Hwang, Kwan-Ki ; Moody, M Anthony ; Haynes, Barton F ; Bonsignori, Mattia ; Sodroski, Joseph ; Kaufmann, Daniel E ; Shaw, George M ; Chenine, Agnès L ; Finzi, Andrés</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-221b901ba9c72826ec13e9c580538c9b6d8160c2672b48aa63c86e7439bc58443</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>AIDS Vaccines - immunology</topic><topic>Amino Acid Motifs</topic><topic>Amino Acid Sequence</topic><topic>Antibody-Dependent Cell Cytotoxicity</topic><topic>Binding Sites</topic><topic>Consensus Sequence</topic><topic>HEK293 Cells</topic><topic>HIV Antibodies - physiology</topic><topic>HIV Envelope Protein gp120 - immunology</topic><topic>HIV Infections - immunology</topic><topic>HIV Infections - prevention &amp; control</topic><topic>HIV Infections - virology</topic><topic>HIV-1 - immunology</topic><topic>Humans</topic><topic>Lentivirus</topic><topic>Pathogenesis and Immunity</topic><topic>Protein Binding</topic><topic>Retroviridae</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Prévost, Jérémie</creatorcontrib><creatorcontrib>Zoubchenok, Daria</creatorcontrib><creatorcontrib>Richard, Jonathan</creatorcontrib><creatorcontrib>Veillette, Maxime</creatorcontrib><creatorcontrib>Pacheco, Beatriz</creatorcontrib><creatorcontrib>Coutu, Mathieu</creatorcontrib><creatorcontrib>Brassard, Nathalie</creatorcontrib><creatorcontrib>Parsons, Matthew S</creatorcontrib><creatorcontrib>Ruxrungtham, Kiat</creatorcontrib><creatorcontrib>Bunupuradah, Torsak</creatorcontrib><creatorcontrib>Tovanabutra, Sodsai</creatorcontrib><creatorcontrib>Hwang, Kwan-Ki</creatorcontrib><creatorcontrib>Moody, M Anthony</creatorcontrib><creatorcontrib>Haynes, Barton F</creatorcontrib><creatorcontrib>Bonsignori, Mattia</creatorcontrib><creatorcontrib>Sodroski, Joseph</creatorcontrib><creatorcontrib>Kaufmann, Daniel E</creatorcontrib><creatorcontrib>Shaw, George M</creatorcontrib><creatorcontrib>Chenine, Agnès L</creatorcontrib><creatorcontrib>Finzi, Andrés</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Prévost, Jérémie</au><au>Zoubchenok, Daria</au><au>Richard, Jonathan</au><au>Veillette, Maxime</au><au>Pacheco, Beatriz</au><au>Coutu, Mathieu</au><au>Brassard, Nathalie</au><au>Parsons, Matthew S</au><au>Ruxrungtham, Kiat</au><au>Bunupuradah, Torsak</au><au>Tovanabutra, Sodsai</au><au>Hwang, Kwan-Ki</au><au>Moody, M Anthony</au><au>Haynes, Barton F</au><au>Bonsignori, Mattia</au><au>Sodroski, Joseph</au><au>Kaufmann, Daniel E</au><au>Shaw, George M</au><au>Chenine, Agnès L</au><au>Finzi, Andrés</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses</atitle><jtitle>Journal of virology</jtitle><addtitle>J Virol</addtitle><date>2017-04-01</date><risdate>2017</risdate><volume>91</volume><issue>7</issue><issn>0022-538X</issn><eissn>1098-5514</eissn><abstract>HIV-1-infected cells presenting envelope glycoproteins (Env) in the CD4-bound conformation on their surface are preferentially targeted by antibody-dependent cellular-mediated cytotoxicity (ADCC). HIV-1 has evolved sophisticated mechanisms to avoid the exposure of Env ADCC epitopes by downregulating CD4 and by limiting the overall amount of Env on the cell surface. In HIV-1, substitution of large residues such as histidine or tryptophan for serine 375 (S375H/W) in the gp120 Phe 43 cavity, where Phe 43 of CD4 contacts gp120, results in the spontaneous sampling of an Env conformation closer to the CD4-bound state. While residue S375 is well conserved in the majority of group M HIV-1 isolates, CRF01_AE strains have a naturally occurring histidine at this position (H375). Interestingly, CRF01_AE is the predominant circulating strain in Thailand, where the RV144 trial took place. In this trial, which resulted in a modest degree of protection, ADCC responses were identified as being part of the correlate of protection. Here we investigate the influence of the Phe 43 cavity on ADCC responses. Filling this cavity with a histidine or tryptophan residue in Env with a natural serine residue at this position (S375H/W) increased the susceptibility of HIV-1-infected cells to ADCC. Conversely, the replacement of His 375 by a serine residue (H375S) within HIV-1 CRF01_AE decreased the efficiency of the ADCC response. Our results raise the intriguing possibility that the presence of His 375 in the circulating strain where the RV144 trial was held contributed to the observed vaccine efficacy. HIV-1-infected cells presenting Env in the CD4-bound conformation on their surface are preferentially targeted by ADCC mediated by HIV-positive (HIV ) sera. Here we show that the gp120 Phe 43 cavity modulates the propensity of Env to sample this conformation and therefore affects the susceptibility of infected cells to ADCC. CRF01_AE HIV-1 strains have an unusual Phe 43 cavity-filling His 375 residue, which increases the propensity of Env to sample the CD4-bound conformation, thereby increasing susceptibility to ADCC.</abstract><cop>United States</cop><pub>American Society for Microbiology</pub><pmid>28100618</pmid><doi>10.1128/JVI.02452-16</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-538X
ispartof Journal of virology, 2017-04, Vol.91 (7)
issn 0022-538X
1098-5514
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5355605
source Electronic Journals Library; PubMed Central (Open Access); MEDLINE
subjects AIDS Vaccines - immunology
Amino Acid Motifs
Amino Acid Sequence
Antibody-Dependent Cell Cytotoxicity
Binding Sites
Consensus Sequence
HEK293 Cells
HIV Antibodies - physiology
HIV Envelope Protein gp120 - immunology
HIV Infections - immunology
HIV Infections - prevention & control
HIV Infections - virology
HIV-1 - immunology
Humans
Lentivirus
Pathogenesis and Immunity
Protein Binding
Retroviridae
title Influence of the Envelope gp120 Phe 43 Cavity on HIV-1 Sensitivity to Antibody-Dependent Cell-Mediated Cytotoxicity Responses
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-14T14%3A34%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20the%20Envelope%20gp120%20Phe%2043%20Cavity%20on%20HIV-1%20Sensitivity%20to%20Antibody-Dependent%20Cell-Mediated%20Cytotoxicity%20Responses&rft.jtitle=Journal%20of%20virology&rft.au=Pr%C3%A9vost,%20J%C3%A9r%C3%A9mie&rft.date=2017-04-01&rft.volume=91&rft.issue=7&rft.issn=0022-538X&rft.eissn=1098-5514&rft_id=info:doi/10.1128/JVI.02452-16&rft_dat=%3Cproquest_pubme%3E1891873821%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1861575715&rft_id=info:pmid/28100618&rfr_iscdi=true